Foundation / Corporation
Kenneth Rainin Foundation
05/21/18 5:00 PM PST
Grants to USA, Canada, and International investigators affiliated with nonprofit research institutions, medical centers, and universities to support high-risk research on inflammatory bowel disease. LOIs are due February 15. This program challenges investigators to push boundaries to further the goal of preventing and predicting inflammatory bowel disease.
Through the Innovator Awards, we invest in new and veteran IBD researchers alike and embrace novel, untested ideas. Our funding interests span the spectrum of basic, translational and clinical science. The Foundation believes substantive collaboration provides the best approach to accelerating our understanding of IBD and improving patient care.
To date, the Foundation has funded the following areas through Innovator Awards:
-Diet and Nutrition
-Epithelial Cell/Molecular Biology
-Fecal Microbiota Transplant
-Immunity and Inflammation
-Therapeutic Development and Delivery
Funding criteria include:
-Strong evidence of collaboration
-Investigator capability to execute project
Basic Science: If your research proposal is rooted in basic science, we encourage you to collaborate with investigators who can further the potential for translation of your ideas and findings.
Translational Science: If your research proposal is translational by nature, we encourage you to identify industry and clinical partners to assist in propelling your research toward clinical study.
Clinical Science: If you are looking to submit a clinical research proposal, we encourage you to collaborate with individuals who could facilitate potential clinical implementation.
Grant recipients are required to attend the Foundation’s annual Innovations Symposium held in July, and may be required to present their work to the general attendees. Grantees are invited to bring a trainee who is working on the project to the Symposium.
The annual Innovations Symposium is a two to three-day meeting held each year in July in San Francisco, California.
Travel costs to attend the Rainin Foundation’s annual meeting must be included in the proposal budget. A portion of the grant may be budgeted for travel to the annual meeting. Eligible costs include: Economy/coach airfare and other transportation. The Rainin Foundation will host hotel expenses for grantees. Innovator Award funding cannot be used to cover travel to attend other scientific meetings.
GrantWatch ID#: 182892
The Innovator Award is for a maximum of $200,000. The budget must reflect the total amount requested, up to $200,000, which may include up to 10% for indirect costs.
Principal Investigator Salary:
The maximum amount allowed for the Principal Investigator’s salary is $10,000 USD. If co-investigator(s) are listed on the proposal, the maximum salary support for all Investigators is $20,000 total. This maximum value does not apply to other research personnel (e.g. post-doctoral fellows, research associates, students) to be funded by the award.
The maximum indirect costs (overhead) that can be requested are 10% of total direct costs. Once a grant has been awarded, funds cannot be transferred out of direct costs to cover indirect or overhead costs, even if the indirect cost was less than the maximum allowed.
A maximum of $2,000 USD can be budgeted for travel to the annual Rainin Foundation meeting.
The Innovator Awards program provides grants for one-year research projects. Recipients who demonstrate significant progress may receive up to two additional years of support.
The grant period is October 1, 2018 – September 30, 2019.
Researchers from any scientific discipline worldwide are eligible for funding. Typically, the researchers funded hold advanced degrees (MD, PhD or the equivalent) and academic positions at universities, medical centers or research institutions. Innovator Awards may have only one principal investigator, and funding is awarded to their home institution; however, additional investigators may be listed as co-investigators.
All nonprofit institutions that are invited to submit a full proposal must provide evidence of tax exempt 501(c)3 status and must be classified as “not a private foundation” under Section 509(a)(3). Nonprofit institutions outside of the United States will be required to undergo Equivalency Determination with NGOsource if awarded funding. For-profit institutions must demonstrate that their proposed project furthers the Foundation’s charitable mission of promoting scientific and medical research. The Foundation may upon occasion make grants to government and public agencies, as well as to independent projects that have a qualified tax-exempt fiscal sponsor.
The Foundation does not fund: direct assistance to individuals or individual sponsorships; sports, athletic events or league sponsorships; advertising or promotional sponsorships; deficits or retroactive funding; fraternal organizations; organizations that discriminate based on religion, race, sexual orientation or gender.
Use of Human and Animal Subjects:
Grant recipients using human or animal subjects must provide documentation of approval from the appropriate review committee before Foundation funds can be released.
Letters of Inquiry are available January 15 and must be submitted by February 15, 2018, 5:00 PM PST.
Full proposals are by invitation only and consist of an expanded description of project objectives, methodologies and milestones to test the innovative idea, project budget, and disclosure of other financial support.
2018 Innovator Awards:
-Letter of Inquiry: Opens January 15 and closes February 15, 2018 at 5:00 PM (PST)
-Notification of Letter of Inquiry Status: April 2018
-Full Proposal (by invitation only): Due May 21, 2018 by 5:00 PM (PST)
-Awards Announcement: August 2018
-Grant Period October 1, 2018 - September 30, 2019
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
For assistance with the online grant system, contact:
Mia deJesus, Grants Officer
For questions about eligibility, research scope or the grant process, contact:
Laura Wilson, PhD, Director
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.